Where Paula's Choice Clinical 1% Retinol Treatment really shines is active ingredient strength, scoring 7.1 compared to Dermalogica Biolumin-C Serum's 4.4. Its formula features Retinol, Palmitoyl Tetrapeptide-7, and Dipotassium Glycyrrhizate in high positions, signalling meaningful concentrations.
Hydration Efficacy is another area of separation. Paula's Choice Clinical 1% Retinol Treatment scores 9.8 here versus 8.1 for Dermalogica Biolumin-C Serum. That difference comes down to how each formula is built — the ingredient list tells the story.
Paula's Choice Clinical 1% Retinol Treatment brings Retinol, Palmitoyl Tetrapeptide-7, and Dipotassium Glycyrrhizate as actives, while dermalogica Biolumin-C Serum relies on Lactic Acid, Tocopherol, and Dipotassium Glycyrrhizate. Both approaches have merit, but the positioning and supporting ingredients make the difference.
At premium pricing with a score of 7.9, Dermalogica Biolumin-C Serum is a decent pick. Paula's Choice Clinical 1% Retinol Treatment sits at the mid-range level with a 8.9 score — the higher investment pays off in formulation quality.